iRhythm Technologies (IRTC) Competitors

Zimmer Biomet (NYSE:ZBH) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Does the media favor ZBH or IRTC?

In the previous week, Zimmer Biomet had 7 more articles in the media than iRhythm Technologies. MarketBeat recorded 20 mentions for Zimmer Biomet and 13 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.71 beat Zimmer Biomet's score of 0.63 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	10 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, ZBH or IRTC?

Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.68B	2.42	$903.70M	$4.52	20.80
iRhythm Technologies	$591.84M	7.87	-$113.29M	-$3.14	-46.48

Which has more risk & volatility, ZBH or IRTC?

Zimmer Biomet has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500.

Do institutionals & insiders believe in ZBH or IRTC?

88.9% of Zimmer Biomet shares are held by institutional investors. 0.7% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Is ZBH or IRTC more profitable?

Zimmer Biomet has a net margin of 11.86% compared to iRhythm Technologies' net margin of -15.90%. Zimmer Biomet's return on equity of 12.73% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	11.86%	12.73%	7.34%
iRhythm Technologies	-15.90%	-101.04%	-9.55%

Do analysts recommend ZBH or IRTC?

Zimmer Biomet currently has a consensus price target of $111.33, indicating a potential upside of 18.41%. iRhythm Technologies has a consensus price target of $138.60, indicating a potential downside of 5.04%. Given Zimmer Biomet's higher possible upside, research analysts plainly believe Zimmer Biomet is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.30
iRhythm Technologies	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90

Summary

Zimmer Biomet beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks.